Dr. Kaukab Azim. MBBS, PhD
description
Transcript of Dr. Kaukab Azim. MBBS, PhD
1
Dr. Kaukab Azim. MBBS, PhD
Gonadal Hormones &
Inhibitors
• Hypogonadism in males and females• Precocious puberty, leiomyoma, endometriosis,
dysmenorhea• Hormonal contraceptives• Menopausal replacement therapy• Infertility• SERMs• Medical abortion• Gonadal hormones agonist and antagonists• Hormonal drugs for some cancers
3
Hypothalamic and
ant. pituitary hormones
Estrogens&
Inhibitors
Progestins&
Inhibitors
Androgens&
Inhibitors
GnRH analogs Natural & Synthetic
Natural and synthetic
Natural and synthetic
GnRH antagonists
SERMs Anabolic steroids
Gonadotropins: FSH LH
Partial agonists &antagonists
Antagonist Antiandrogens-Gn release inhibitors-Receptors inhibitors-5-a reductase inhibitor-Synthesis inhibitor
Aromatase inhibitors
Gonadal Hormones and Inhibitors
4
Key concepts of Pharmacology of Gonadal Hormones:
• Effects of GnRH release frequency on gonadotropin release.
• Interaction between estrogen and the pituitary gland.
• Tissue selectivity of estrogen agonists and antagonists.
• Various strategies to antagonize the effect of endogenous sex hormones.
Hypothalamus-Pituitary-Gonadal Axis
(Ovulation inducer)
5
Gonadotropin releasing hormone (GnRH)
released in “pulsalite manner” from the hypothalamus and acts on Pituitary to
stimulate the secretion of gonadotropins-FSH & LH
6
GnRH analogsShort-acting analogs
• Gonadorelin (t1/2 = 4 min.)
It can be used in “Pulsatile” manner to stimulate pituitary to secrete FSH and LH.
Uses: • Diagnostic purpose• In infertility: Hypothalamic
amenorrhea
Long-acting analogs
• Goserelin• Nafarelin- nasal spray• Leuprolide
After initial stimulation, they will cause suppression of gonadotropin (FSH, LH) secretion. (down-regulation)
7
GnRH analogsLong-acting GnRH analogs
• Goserelin• Nafarelin• Leuprolide
After initial stimulation, they will cause suppression of gonadotropin (FSH, LH) secretion.
Therapeutic Uses:For Medical castration:
• In precocious puberty• Breast Ca• Prostate Ca• Leiomyoma• Endometriosis
8
GnRH analogs: Adverse effects
Adverse effects of long-acting analogs:• Gonadal steroidal inhibition in females can
cause:– Hot flashes– Vaginal atrophy– Decreased bone density
9
GnRH antagonist
– Ganirelix– Cetrorelix
These are pure GnRH antagonists and do not cause initial increase in gonadotropin secretion.
10
Gonadotropins: FSH & LH
Gonadotropin preparations:– Menotropins (LH + FSH)– Recombinant FSH and LH– hCG (Human chorionic gonadotropin)
11
Estrogens
Physiological Role:• Secondary sexual characteristics• Menstrual cycle
– During follicular phase it cause endometrium to grow
• For normal mineralization and osteoid formation– Deficiency of estrogens cause osteoporosis
12
EstrogensNatural estrogens• Estradiol• Estriol• Estrone
Synthetic estrogens• Ethinyl estradiol• Mestranol
13
Estrogens• Oral:
– Estradiol: micronized form– Conjugated estrogens: conjugated equine estrogens– Ethinyl estradiol & Mestranol (synthetic estrogens)
• IM: aqueous or oil based esters of estradiol and estrione
• Transdermal preparations: estradiol
14
Uses of Estrogens• Hormone Replacement therapy:
– Primary hypogonadism– Premature ovarian failure; surgical removal of ovaries – Menopause
• Oral contraception
• Osteoporosis
• Atrophic vaginitis
15
Estrogens: Adverse effects
• Nausea, vomiting• Thromboembolic problems• Myocardial infarction• Breast Ca• Endometrial Ca• Postmenopausal uterine bleeding• Diethylstilbestrol: Clear cell Ca (cervical & vagina)
16
Progestins
• Physiological role: – helps maintaining pregnancy
• They are often combined with estrogen in various formulations to counteract the harmful effects of estrogens– Estrogen can cause endometrial carcinoma
17
ProgestinsNatural progestins:
– Progesterone, 17-alpha hydroxyprogesterone
Synthetic progestins:– Hydroxyprogesterone (IM, every 1-2 weeks)– Medroxyprogesterone (Oral-daily, IM every 1-3 months)– Norethindrone: belongs to 19-nortestoserone analogs– Norgestrel, Levonorgestrel– Norgestimate (less androgenic)– Desogestrel (less androgenic)
18
Progestins: Uses
• As contraceptive and menopausal hormone therapy– Combined with estrogen (in COCPs & menopausal hormonal
therapy) – Progestin only contraceptive preparations– As postcoital contraception
• Dysmenorrhea• Dysfunctional uterine bleeding • Endometriosis
19
Progestines: Adverse effects– Edema– Depression
ADRs of progestins having Androgen-like activity:– Increase the ratio of LDL to HDL cholesterol– Thrombophlebitis– Pulmonary embolism– Acne– Hirsutism– Weight gain
20
Hormonal Contraceptives
• Combined Oral Contraceptive Pills (COCPs)– contain both estrogen and progesterone– Monophasic, Biphasic, Triphasic forms
• Progestin only preparations– Progestin-only pills (“mini-pill”)– Progestin implants/depot (Levonorgestrel, medroxyprogesterone)
– Progestin containing Intrauterine device
• Postcoital contraception (emergency contraception)
21
COCPs: Mechanism of action
1. Estrogen and progesterone causes feedback inhibition of FSH and LH secretion from the pituitary gland to inhibit ovulation. (main mechanism)
2. Progestins thicken the cervical mucous and prevent the entry of sperm.
3. Effects on uterine tubes and endometrium decrease the likelihood of fertilization and implantation
Feedback inhibition
↓ LH surge
No Ovulation
22
COCPs: Adverse effects
• Nausea, vomiting, mastalgia• Headache• Breakthrough bleeding• Wt. gain• Acne and Hirsutism (19-nortestosterone derivatives)• Chloasma (skin pigmentation)
23
COCPs: Serious complications
• Leg vein and pulmonary thrombosis• Coronary and cerebral thrombosis• Rise in BP
24
COCPs: Contraindications
COCPs are absolutely contraindicated in • Thromboembolic, coronary, cerebrovascular disease.
Greater risk for :– Women > 35 years of age– Heavy smokers– Obese
• Active liver disease• Suspected or overt malignancy of genitals/breast• Undiagnosed vaginal bleeding
25
COCPs: Relative contraindications
• Hypertension• Migraine• Diabetes mellitus• Uterine leiomyoma• Mental illness• Gall bladder disease
26
COCPs: Drug Interactions
• Enzyme inducers (Phenytoin, barbiturates, carbamazapine, Rifampin) cause contraceptive failure
• Antibiotics (Tetracyclines, ampicillin, etc.) cause contraceptive failure by suppressing intestinal microflora:
– Decreased deconjugation of estrogens excreted in bile – Decreased enterohepatic circulation of estrogens – Blood levels of estrogens fall contraceptive failure
27
Progestin-only preparations• Progestin-only pill (“Mini-pill”)
– norethindrone or levonorgestrel
• Progestin implants/depot– Levonorgestrel: subcutaneous implant, 5 years– Medroxyprogesterone acetate (DMPA): IM, every 3
months.
• Progestin containing Intrauterine devices– Progestasert contains progesterone & mirena contains levonorgestrel
28
Progestin-only preparations
Progestin-only preparations are suitable for women when estrogens are contraindicated :
• Smokers• Age > 35 years• h/o cardiovascular disease• Migraine• Liver impairment
29
Progestin-only preparations
Disadvantages of progestins:
• Frequent spotting• Irregular and unpredictable menstrual cycles• Failure rate is higher as compared to combined
COCPs• Unfavorable effect on lipid profile
30
Emergency contraception• Postcoital or “morning after” contraception
1. Combined oral contraceptive pills: 2 pills within 72 hours of unprotected sexual intercourse and 2 exactly 12 hours later.
2. Progestin-only pills (Levonorgestrel): one tablet within 72 hours of unprotected sexual intercourse followed by second dose exactly 12 hrs later.
3. Ulipristal: a selective progesterone receptor modulator; taken within 120 hrs of unprotected sexual intercourse
31
Menopausal hormone therapy(HRT)
• Estrogen deficiency symptoms:– Hot flashes, chills, night sweats, mood swings, insomnia,
headache, palpitation– Vaginal and urethral atrophy– Osteoporosis (others drugs are preferred)
• Lowest effective dose of estrogen for the shortest duration to relieve estrogen deficiency symptoms in postmenopausal period.
32
Selective estrogen receptor modulators(SERMs)
Tamoxifen, Raloxifene
These are drugs that interact with estrogen receptors but have different effects on different tissues. They can show agonism or antagonism depending upon the tissue type.
33
Tamoxifen
• Antiestrogenic effect: on Breast– Effective in the treatment of breast Ca in patients with tumor
cells that are estrogen receptor- positive.– can be given after surgery to eradicate micrometastases
• Estrogenic effect: on Endometrium– Can cause endometrial Ca– Not prescribed to treat breast Ca for longer than 3-5 years in
non-hysterectomized women
34
Tamoxifen: Adverse effects
• Nausea/Vomiting• Hot flashes• Vaginal bleeding• Risk of Endometrial Ca• Thromboembolic disorders
35
Raloxifene
• Antiestrogenic effect: Breast, Endometrium
• Estrogenic effect: Bones, lipid metabolism
– Unlike Tamoxifen, it does not increase the risk of endometrial Ca.
– Approved to be used for the prevention of osteoporosis in postmenopausal women
36
Estrogen antagonists
• Clomiphene (Ovulation inducer):blocks estrogen receptors in the hypothalamus and anterior pituitary
reduces negative feedback
↑ FSH and LH secretionovarian follicle development and ovulation
• Fulvestrant
37
Progesterone antagonist
• Mifepristone (RU 486)– Progesterone receptor antagonist– Glucocorticoid receptor antagonist
Therapeutic uses:– Medical termination of pregnancy
(Mifepristone followed 48 hrs later by Misoprostol)
Aromatase inhibitors• Anastrozole, Letrozole : non-steroidal agents;
competitive inhibitors• Exemestane : steroidal agent; irreversible inhibitor
38
Estradiol
Estrone
Estriol
39
Aromatase inhibitors• Aromatase inhibitors block the synthesis of estrogens
from androgen precursors by inhibiting aromatase enzyme.
• This approach can be used to inhibit the growth of estrogen-dependent tumors e.g., breast cancer.
• Used in postmenopausal women with advanced breast cancer– Unlike tamoxifen, they do not increase the risk of
endometrial carcinoma or venous thromboembolism.
• Endometriosis
40
AndrogensTestosterone esters:• Testosterone propionate• Testosterone enanthate• Testosterone cypionate
17-alpha alkylated androgens:• Methyltestosterone• Fluoxymesterone• Oxandrolone (anabolic steroid)• Danazol (Danocrine)
41
Androgens: Therapeutic Uses• Hypogonadism: as hormonal replacement therapy.
• For Anabolic effects: – Osteoporosis– severe burns – to increase lean body mass, muscle strength
• Endometriosis
• Hereditary angioedema
42
Danazolsynthetic derivative of 17-ethinyltestosterone
• It has weak androgenic, progestational and glucocorticoid activity
• Inhibits CYP450 enzymes involved in gonadal hormone synthesis
Uses:– Endometriosis– Fibrocystic breast disease– Hereditary angioedema (It occurs due to deficiency of C1-
esterase inhibitor)
43
Danazol: Adverse effects
• Acne• Hirsutism• Menstrual irregularities• Hepatotoxicity• Thromboembolism• Teratogenic
44
Anabolic steroids• Greater anabolic:androgenic activity• Oxandrolone (anabolic: androgenic=3:1-13-1)
Adverse drug reactions:• Infertility: due to suppressed FSH and LH
– Decreased testicular size and function• Feminization in men, gynecomastia• Masculinization in women: Hirsutism, deepening of
voice, menstrual irregularities• Hepatic dysfunction, Cholestatic jaundice• Psychotic symptoms
45
Antiandrogens
– Gonadotropin release inhibitors
– Androgen Receptor blockers
– 5a-reductase inhibitor– Androgen synthesis
inhibitors
46
Gonadotropin release inhibitors
• Long acting GnRH analogs– Leuprolide– Goserelin– Nafarelin
47
Androgen Receptor blockers• Nonsteroidal antiandrogens
– Flutamide– Bicalutamide
• They block the action of dihydrotestosterone on testosterone receptors and inhibit the synthesis of new proteins in prostate and prostate cancer cells.
• Combined with GnRH analogs to treat inoperable prostate Ca.
48
Androgen receptor blockers: Adverse effects
• Gynecomastia or nipple tenderness• Diarrhea• Hepatotoxicity • Impotence
49
5a-reductase inhibitor• In the prostate, testosterone is converted into
dihydrotestosterone (DHT) by the action of 5a-reductase
• DHT acts on prostate cells to stimulate new growth
• Finastride: synthetic testosterone derivative– It inhibits the synthesis of Dihydrotestosterone
(DHT) by inhibiting 5a-reductase
50
5a-reductase inhibitor
Therapeutic uses:• Benign prostatic hyperplasia• Male pattern baldness
51
Androgen synthesis inhibitors
• Ketoconazole:– It is an antifungal agent.– It inhibits gonadal & adrenal steroid synthesis by
inhibiting cholesterol side chain cleavage (inhibits P450SCC).
Adverse effects:– Gynecomastia– hepatotoxicity
52
Hormones in cancer chemotherapy
Used as adjunctive therapy
Breast Ca Prostate Ca
Anastrozole, Exemestane Flutamide, Bicalutamide
Tamoxifen Leuprolide, Goserelin
Leuprolide, Goserelin
Glucocorticoids